Company Profile
Beam Therapeutics Stock Price, News & Analysis
Company overview
Business overview
Beam Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Beam Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Beam Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Beam Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Why the stock is moving
BEAM is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Beam has a more tangible path now with BEAM-304 in PKU and BEAM-302 in alpha-1 antitrypsin deficiency. The new liver-targeted program broadens the platform, but the next real test is whether the gene-editing work keeps producing human data that looks good enough to support a deeper development push.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Beam Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates
Source: Beam Therapeutics
- 02
Beam Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates
Source: Beam Therapeutics
- 03
Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference
Source: Beam Therapeutics
- 04
- 05
Beam Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
Source: Beam Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.